Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene

Behavioural Brain Research

Volumn 144, Issue 1-2, 2003, Pages 111-117

  Ouagazzal, A M ^a   Moreau, J L ^b   Pauly Evers, M ^b   Jenck, F ^c  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

Anxiety; Mice; N OFQ; Stress

Indexed keywords

DRINKING WATER; NOCICEPTIN; PEPTIDE;

AGGRESSION; ANIMAL EXPERIMENT; ANXIETY; ANXIETY DISORDER; ARTICLE; AUDITORY STIMULATION; BRAIN FUNCTION; COMPETITION; CONTROLLED STUDY; EMOTION; ENVIRONMENT; FEAR; FEMALE; FOOD; GENE; GENE DISRUPTION; GENE TARGETING; HEARING; HOMOZYGOSITY; HOUSING; IMMOBILIZATION STRESS; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOUSE; MUTANT; NEUROLOGIC EXAMINATION; NOCICEPTION; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; SMELLING; SOCIAL BEHAVIOR; STARTLE REFLEX; STRESS; TOUCH; VISION; WILD TYPE;

EID: 0041386226     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(03)00066-4     Document Type: Article

References (26)

1. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P.et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
2. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R.et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
3. Calo G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129:2000;1261-1283.
4. Darland T., Heinricher M.M., Grandy D.K. Nociceptin/orphanin FQ: a role in pain and analgesia but so much more. Trends Neurosci. 21:1998;215-221.
5. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406:1999;503-547.
6. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport. 8:1996;369-371.
7. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci. 9:1997;194-197.
8. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M.et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature. 394:1998;577-581.
9. Jenck F., Moreau J.-L., Martin J.R., Kilpatrick G., Reinscheid R., Monsma F.J.et al. Orphanin FQ acts as anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. 94:1997;14854-14858.
10. Gavioli E.C., Rae G.A., Calo' G., Guerrini R., Lima T.C. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test. Br. J. Pharmacol. 136:2002;764-772.
11. Griebel G., Perrault G., Sanger D.J. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res. 836:1999;221-224.
12. Kyuhou S.-I., Gemba H. Injection of nociceptin/orphanin FQ into the periaqueductal gray suppresses the forebrain-elicited vocalization in the guinea pig. Neurosci. Lett. 260:1999;113-116.
13. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.-L., Ouagazzal A.-M., Martin J.R.et al. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad Sci. 97:2000;4938-4943.
14. Ciccocioppo R., Biodini M., Antonelli L., Wichmann J., Jenck F., Massi M. Reversal of stress- and CRF-induced anorexia in rats by synthetic nociceptin/orphanin FQ receptor, agonist Ro-64-6198. Psychopharmacology. 161:2002;113-119.
15. Köster A., Montkowski A., Schulz S., Stübe E.-M., Knaudt K., Jenck F.et al. Targeted disruption of nociceptin/orphanin FQ gene increases stress succeptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. 96:1999;10444-10449.
16. Banbury Conference on genetic background in mice. Mutant mice and neuroscience: recommendations concerning genetic background. Neuron 1997;19:755-759.
17. Irwin S. Comprehensive observational assessment. Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 1968;222-257.
18. Hatcher J.P., Jones D.N.C., Rogers D.C., Hatcher P.D., Reavill P.D., Hagan J.J.et al. Development of SHIRPA to characterize the phenotype of gene-targeted mice. Behav. Brain Res. 125:2001;43-47.
19. Hilakivi L.A., Lister R.G. Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral despair. Pharmacol. Biochem. Behav. 33:1989;371-374.
20. Rodgers R.J., Cole J. Influence of social isolation gender strain, and prior novelty on plus-maze behaviour in mice. Physiol. Behav. 54:1993;729-736.
21. Karolewicz B., Paul I.A. Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. Eur. J. Pharmacol. 415:2001;197-201.
22. Van Loo P.L., Mol J.A., Koolhaas J.M., Van Zutphen B.F., Baumans V. Modulation of aggression in male mice: influence of group size and cage size. Physiol Behav. 72:2001;675-683.
23. Servatius R.J., Ottenweller J.E., Bergen M.T., Soldan S., Natelson B.H. Persistent stress-induced sensitization of adrenocortical and startle responses. Physiol. Behav. 56:1994;945-954.
24. Walker D.L., Davis M. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol. Psychiatry. 42:1997;461-471.
25. Reinscheid RK, Köster A, Knaudt K, Montkowski A, Civelli O. Increased stress susceptibility and fear in orphanin FQ/nociceptin knockout mice is dependent on chronic social stress. Soc Neurosci 1999;25:Abst. 590.5.
26. Florin S., Leblond F., Suaudeau C., Meunier J.-C., Costentin J. Comparison of behavioural effects of NOCII or NOCIII, two related pronociceptin-derived peptides. Life Sci. 65:1999;2727-2733.